CRYOPRESERVATION OF IMMATURE BUFFALO OOCYTES BY VITRIFICATION

Authors

Artificial Insemination and Embryo Transfer Department, Animal Reproduction Research Institute, Al Haram, Giza, Egypt.

Abstract

Cryopreservation of collected oocytes from slaughtered animals of high genetic value, for production of embryos may provide an opportunity to replenish the valuable germplasm lost. The aim of this study was to cryopreserve the immature buffalo oocytes by vitrification. Experiments were conducted to study the effect of using different ethylene glycol concentrations (10, 20 and 40%) in the equilibration solution, equilibration periods (3, 5 and 10 min) and vitrification solutions (ethylene glycol with 0.5 M sucrose, 0.3 M trehalose and 20% dimethyl sulfoxide) with a non vitrified group served as control on morphological survival, in vitro maturation and embryo development of vitrified-warmed immature buffalo oocytes. The selected cumulus oocyte complexes with compacted cumulus cells and evenly granulated ooplasm were vitrified. The present results revealed that, equilibration solution and equilibration time significantly (P < 0.01) decreased the proportion of morphologically normal oocytes. Using sucrose in the vitrification solution, an equilibration time of 5 min and an equilibration solution with 20% ethylene glycol (EG) yielded the highest proportion of morphologically normal oocytes (93.73%) and the lowest proportion of morphologically abnormal oocytes (6.11%). Moreover, vitrification of buffalo oocytes with different vitrification solutions, sucrose, trehalose or DMSO, significantly (P < 0.5) decreased the in vitro maturation rate (47.27, 26.92 and 42.03%, respectively), in vitro fertilization rate (30.36, 13.21 and 23.08%, respectively), cleavage rate (23.91, 6.67 and 21.43%, respectively) and morula development (4.35, 0.00 and 2.38%, respectively) compared to the control treatment (78.67, 58.73, 44.64 and 19.64%, respectively). The current results also showed that, all the oocytes that vitrified in different vitrification solutions failed to develop to the blastocyst stage compared to the control treatment (10.71%). Therefore, from the current results we can conclude that immature buffalo oocytes could be frozen by vitrification technique. Acceptable vitrification protocol of immature buffalo oocytes was observed when immature buffalo oocytes were vitrified using 20% EG in the equilibration solution, an equilibration time of 5 min, and a vitrification solution containing 20% EG and 0.5 M sucrose. However, further studies are needed to improve the in vitro embryo development of the vitrified buffalo oocytes.

Keywords


Artificial Insemination and Embryo Transfer Department,

Animal Reproduction Research Institute, Al Haram, Giza, Egypt.

 

Cryopreservation of immature buffalo oocytes by vitrification

(With 6 Tables)

 

By

M.R. Badr; G.M. Darwish and D.A. El-Badry

(Received at 13/3/2008)

 

تجميد بويضات الجاموس الغير ناضجة بالتزجج

 

مجدي رمضان بدر ، جمال مصطفي درويش ، ضياء الدين البدري

 

تعتبر عملية تجميد بويضات الحيوانات الغير ناضجة واستخدامها بعد الإسالة لإنتاج أجنة صالحة للنقل للام المستقبلة من أهم الوسائل الحديثة للحفاظ علي الصفات الو راثية الممتازة. وبالرغم من ذلک مازالت طرق تجميد البويضات الغير ناضجة تعطى نتائج ضعيفة مقارنة بطرق تجميد الأجنة. ولهذا تهدف الدراسة الحالية إلي دراسة بعض العوامل التي قد تؤثر في نجاح عملية تجميد البويضات مثل تحديد احسن ترکيز من الاثيلين جليکول (10, 20 ,40%) في محلول الاتزان قبل وضع البويضات في محلول التجميد النهائي (محلول التزجج) وکذلک انسب وقت لتحضين البويضات في محلول الاتزان (3, 5, 10 دقيقة) قبل وضعها في محلول التزجج النهائي وکذالک دراسة تأثير إضافة السکروز والتريهالوز والميثيل سلفوکسيد إلى محلول التزجج لدراسة تأثير هذة العوامل علي الشکل الظاهري للبويضات بعد الإسالة وقدرتها علي النضوج والإخصاب والنمو معمليا. ولقد أوضحت نتائج الدراسة الحالية أن محلول الاتزان ووقت الاتزان يؤثران تأثيرا معنويا کبيرا علي الشکل الظاهري للبويضات بعد التجميد والإسالة. فلقد تبين من نتائج الدراسة الحالية أن استخدام ترکيز20% من الاثيلين جليکول في محلول الاتزان وتحضين البويضات في محلول الاتزان لمدة  5 دقائق مع إضافة السکروز إلى محلول التزجج أدى إلي استخلاص أعلى معدل للبويضات السليمة ظاهريا (93.73%) واقل معدل للبويضات الغير سليمة من الناحية الظاهرية (6.11%). کما أوضحت نتائج الدراسة الحالية أن تزجج بويضات الجاموس الغير ناضجة في محلول التزجج الذي يحتوي علي السکروز أو التريهالوز أو الميثيل سلفوکسيد  نتج عنة انخفاض معنوي کبير في معدل النضوج (47.27 ,26.92, 42.03 % علي التوالي) وإخصاب البويضات (30.36 , 13.21 , 23.08% علي التوالي) وانقسام الأجنة معمليا (23.91 , 6.67 ,  21.43% علي التوالي) ومعدل نمو الأجنة إلى الطور التوتي   (4.35, 0.00 , 2.38 % علي التوالي) مقارنة بالمجموعة الضابطة (78.67 , 58.36 , 44.64 , 19.64 % علي التوالي).  کذلک أوضحت نتائج الدراسة الحالية أن جميع البويضات  المزججة لم تنمو إلى طور البلاستوست مقارنة بالمجموعة الضابطة  (10.71%). ولهذا يمکن أن نستنتج من هذه الدراسة أن بويضات الجاموس الغير ناضجة يمکن أن تحفظ بطريقة التزجج ويتضح ذلک من المحافظة علي الشکل الظاهري للبويضات  وقدرتها علي النمو معمليا. کما يتضح من  الدراسة الحالية أن أحسن طريقة لتزجج بويضات الجاموس الغير ناضجة هي وضع البويضات الغير ناضجة في محلول الاتزان الذي يحتوي علي 20% ايثلين جليکول لمدة 5 دقائق ومحلول التزجج 20% ايثلين جليکول و0.5 مول سکروز. ولکن لا يزال مطلوب اجراء العديد من الدراسات لتحسين معدلات نمو الأجنة معمليا من البويضات المجمدة.

 

SUMMARY

 

Cryopreservation of collected oocytes from slaughtered animals of high genetic value, for production of embryos may provide an opportunity to replenish the valuable germplasm lost. The aim of this study was to cryopreserve the immature buffalo oocytes by vitrification. Experiments were conducted to study the effect of using different ethylene glycol concentrations (10, 20 and 40%) in the equilibration solution, equilibration periods (3, 5 and 10 min) and vitrification solutions (ethylene glycol with 0.5 M sucrose, 0.3 M trehalose and 20% dimethyl sulfoxide) with a non vitrified group served as control on morphological survival, in vitro maturation and embryo development of vitrified-warmed immature buffalo oocytes. The selected cumulus oocyte complexes with compacted cumulus cells and evenly granulated ooplasm were vitrified. The present results revealed that, equilibration solution and equilibration time significantly (P < 0.01) decreased the proportion of morphologically normal oocytes. Using sucrose in the vitrification solution, an equilibration time of 5 min and an equilibration solution with 20% ethylene glycol (EG) yielded the highest proportion of morphologically normal oocytes (93.73%) and the lowest proportion of morphologically abnormal oocytes (6.11%). Moreover, vitrification of buffalo oocytes with different vitrification solutions, sucrose, trehalose or DMSO, significantly (P < 0.5) decreased the in vitro maturation rate (47.27, 26.92 and 42.03%, respectively), in vitro fertilization rate (30.36, 13.21 and 23.08%, respectively), cleavage rate (23.91, 6.67 and 21.43%, respectively) and morula development (4.35, 0.00 and 2.38%, respectively) compared to the control treatment (78.67, 58.73, 44.64 and 19.64%, respectively). The current results also showed that, all the oocytes that vitrified in different vitrification solutions failed to develop to the blastocyst stage compared to the control treatment (10.71%). Therefore, from the current results we can conclude that immature buffalo oocytes could be frozen by vitrification technique. Acceptable vitrification protocol of immature buffalo oocytes was observed when immature buffalo oocytes were vitrified using 20% EG in the equilibration solution, an equilibration time of 5 min, and a vitrification solution containing 20% EG and 0.5 M sucrose. However, further studies are needed to improve the in vitro embryo development of the vitrified buffalo oocytes.

 

Key words: Cryopreservation, buffalo, oocytes vitrification

 

Introduction

 

In vitro embryo production technology may represent the best tool to improve genetic progress in buffalo, due to limitation of multiple ovulation and embryo transfer programs (Zicarelli, 1997). The main inadequacy of the embryo production technology in buffalo is represented by the low number of oocytes recoverable (Gasparrini, 2002). In this scenario, oocyte cryopreservation in buffalo is fundamental to increase the availability of female gametes for both research purposes and future commercial use (Gasparrini et al., 2006).  Oocyte cryopreservation is still an open challenge in most mammalian species, due to the extreme sensitivity of gametes to chilling injuries. However, vitrification has been used successfully to cryopreserve bovine (Vieira et al., 2002), mouse (Wood et al., 1993), equine (Maclellan et al., 2002) and human oocytes (Bankowski et al., 2005). Vitrification is a procedure that shortens the period of exposure to cryoprotectant solutions through the immediate plunging of material into liquid nitrogen (Vajta, 2000). This process results in the solidification of the material without formation of ice crystals, minimizing injuries to the oocyte cytoskeleton (Coticchio et al., 2004). With the vitrification procedure, the exposure time of oocytes to cryoprotectant solutions must be short due to toxic effect of high cryoprotectant concentrations (Papis et al., 2000).  However, if the exposure is to short, the penetration of the cryoprotectant will be inadequate and intracellular ice could form, even in the absence of extracellar ice (Otoi et al., 1998).Different cryoprotectants are used for vitrification of of mammalian oocytes and embryos from various mammalian oocytes and embryos (Vieira et al., 2004).The most widely used vitrification cryoprotectants are ethylene glycol (EG), propylene glycol, glycerol, and dimethyl sulphoxide (DMSO), employed in different combinations and concentrations. Several studies demonstrated that ethylene glycol would be the ideal cryoprotectant (Shaw et al., 1997), because it penetrates membranes faster than glycerol (Cha et al., 2000) and is less toxic than other permeable cryoprotectants (Martino et al., 1996 and Dinnyes et al., 2000). Moreover, freezing solutions containing permeable (usually ethylene glycol) and non-permeable cryoprotectants, seem to be more advantageous than solutions containing just a permeable cryoprotectant (Shaw et al., 2000). The addition of a sugar (sucrose, glucose, fructose, sorbitol, saccharose, trehalose, or raffinose) to an EG-based vitrification solution influenced the overall properties of the solution (Kuleshova et al., 1999). The disaccharides, sucrose and trehalose, are the most common non-permeable cryoprotectants used for oocyte cryopreservation. Sucrose acts as a stabilizer, minimizing the effects of high concentrations of ethylene glycol (Rayos et al., 1994). Trehalose seems to act directly on lipids and proteins of the membrane, altering their behavior (Holt, 2000), and replacing water molecules on the membrane surface, thus inhibiting denaturation and aggregation of proteins during dehydration (Puhlev et al., 2001). Therefor, the aim of the present study was to determine, the effect of equilibration solution, equilibration time, and the addition of two disacchrides in the vitrification solution in combination with ethylene glycol on immature buffalo oocytes vitrification and subsequent development in vitro.

 

MaterialS and methods

 

Collection of cumulus-oocyte complexes (COCs)

Ovaries were obtained from buffalos at a local slaughterhouse. Immediately after slaughter and evisceration, ovaries were removed and placed in thermo flasks containing physiological saline, supplemented with antibiotic and antimycotic at 38°C. At the laboratory, oocytes were harvested from ovaries by aspirating the follicles (≤ 8 mm) using an 18 gauge needle attached to a 5 ml syringe. Only oocytes with at least three layers of compact cumulus cells and a homogeneous ooplasm were selected and used in the present experiments.

Experimental design

The experimental design was set up to study the effect of ethylene glycol (EG) concentrations (10, 20 and 40%) in the equilibration solutions (ES), equilibration time (3, 5 and 10 min) on the morphological characteristics of the vitrified buffalo oocytes and the effect of addition of a sugar (0.5 M sucrose and 0.3 M trehalose) to an EG-based vitrification solutions on the in vitro maturaion, fertilization and subsequent development of the vitrified buffalo oocytes. The control treatment had fresh oocytes that, immediately after selection, were submitted to the in vitro maturation (IVM) procedure.

Cryopreservation of COCs:

Equilibration and vitrification

The basic holding medium used for manipulation, equilibration, vitrification, and rehydration, was phosphate buffer saline supplemented with 0.4% of bovine serum albumin (Sigma). For equilibration, oocytes of each treatment were kept in an ES for 3, 5 or 10 min. After the end of the equilibration time, oocytes were transferred to VS. Oocytes of all treatments were maintained in the vitrification solution (VS), for one minute. During this time, oocytes were loaded into 0.25 mL straws in the following order: a column of VS, an air bubble, a column of VS containing six to ten oocytes, an air bubble, and a column of VS. The straws were then sealed and plunged directly into liquid nitrogen at the end of one minute. Each straw was stored in liquid nitrogen for a minimum of 10 days according to Martins et al. (2005).

Thawing and rehydration

The oocytes of all treatments were thawed by immersion of straws in a water bath at 37°C for 30 sec. After immersion in the water bath, oocytes were rehydrated in sucrose or trehalose solutions. Oocytes were expelled into the holding medium with 0.5 M sucrose or0.3 M trehalose or sucrose and held for 5 min for one step rehydration. The oocytes were then transferred to fresh washing medium and were washed 4 times. The recovery rate was definied as the number of oocytes counted after the end of rehydration, in relation to the total of oocytes vitrified. The morphological appearance of oocytes after warming was evaluated under an inverted microscope. The oocytes with spherical and symmetrical shape and no signs of degeneration were considered normal and submitted to in vitro maturation, whereas oocytes with ruptured zona pellucida, ruptured vitelline membrane or having fragmented cytoplasm with degenerative signs were classified as abnormal and discarded.

In vitro maturation of the vitrified-thawed oocytes

The maturation medium used was TCM 199 (Sigma) supplemented with 10% FCS. In vitro maturation was carried out in Petri dishes (35mm diameter), previously equilibrated for at least 2 h at 38.5oC in a moist atmosphere of 5% CO2 in air. Oocytes were cultured in these conditions for 24 h. After this period, maturation rate was evaluated according to Dhali et al. (2000). 

Evaluation of maturation status

After 24 h of culture, cumulus cells were removed from the COCs by repeated pipetting. Clean glass slides were prepared by laying two parallel thin rails of vaseline paraffin along with the breadth of the slide in its center. Five denuded oocytes were then placed on a slide with minimum medium. Cover slip was placed on the vaseline paraffin rails and pushed down until fluid contacted the coverslip. Oocytes were watched carefully while pressing further, under a stereo-microscope, so as to get a good squash without breaking the zona pellucida of the oocytes. The small space left between the slide and coverslip was flushed with maturation medium. Vaseline paraffin was put on the edges of the coverslip and slide was immersed in acid–methanol for 24 h. After fixation, the slides were gently removed from the jar, the excess fixative was dried and the oocytes were stained with 1% (w/v) orcein stain for    5 min. The slides were examined under phase contrast microscope to access the state of nuclear maturation according toCosta et al. (1997).

In vitro fertilization (IVF) and in vitro culture (IVC)

Frozen-thawed sperm were treated by swim-up procedure in S-TALP medium for 1 h. The pellet obtained after centrifugation of supernatant was resuspended in the fertilization medium supplemented with 20µg heparin for in vitro sperm capacitation and a final concentration of 2×106 sperm cell/ml were used to in vitro fertilization. Insemination was performed in 50 µl drops of IVF medium under mineral oil over a 24 h period at 38.5 oC under humidified 5% CO2 in air. Approximately 24 h after IVF, putative zygotes were washed twice in a Hepes-buffered TCM-199 and cultured in TCM-199 medium with Hepes modification for 7- days at 38.5 oC in an atmosphere of 5% CO2 in air with maximum humidity. The proportional of cleaved oocytes was recorded 48 hour after insemination (day 0 = day of insemination), the uncleaved oocytes were discarded and embryos were transferred into fresh medium. On day 5- 7, the percentage of morula and blastocysts was recorded according to Lim et al. (1999).

Statistical analysis:

Data of recovery rate and morphological characteristics of the vitrified oocytes were analyzed by using Costat Computer Program, Version 3.03 copyright (1986), and were compared by the least significant difference least (LSD) at 1% and 5% levels of probability.  The results were expressed as means ± S.E.M. Differences in the maturation rate, fertilization rate, cleavage, morula and blastocyst development among different treatment groups were initially compared using Chi-square (χ2) analysis.

 

Results

 

Data presented in Tables 1, 2 and 3 revealed that, equilibration solutions, equilibration times and vitrification solutions did not influence the oocytes recovery rate. However, the equilibration solutions and equilibration times influence significantly (P<0.01) the proportion of morphologically normal oocytes. Using sucrose in the vitrification solution, (Table 1), an equilibration time of 5 min and an equilibration solution with 20% ethylene glycol (EG) yielded the highest proportion of morphologically normal oocytes (93.73%) and the lowest proportion of morphologically abnormal oocytes (6.11%). Similarly, the results presented in Table 2 demonstrated that, using trehalose in the vitrification solution, an equilibration time of 5 min and an equilibration solution with 20% EG yielded the highest proportion of morphologically normal oocytes (83.68%) and the lowest proportion of morphologically abnormal oocytes (16.32%). Wheras, using DMSO in the vitrification solution, (Table 3) an equilibration time of 3 min and an equilibration solution with 20% EG yielded the highest proportion of morphologically normal oocytes (91.46%) and the lowest proportion of morphologically abnormal oocytes (8.54%). Moreover, the present results showed that, increased the concentration of equilibration solution (40% EG) and equilibration time (10 min) with all the vitrification solutions used in the currant study, yielded the lowest proportion of morphologically normal oocytes (59.46, 58.43 and 68.49%, respectively) and the highest proportion of morphologically abnormal oocytes (40.54, 41.57 and 31.51%, respectively).

 

Table 1: Effect of equilibration solution and equilibration time on the morphology of buffalo oocytes that vitrified with solution containing 0.5 M sucrose.

 

Morphological

abnormal  oocytes

Morphological

normal oocytes

Recovery rate

No. Of vitrified oocytes

Treatments

ET

ES

9.88±2.35d

89.80±2.50a

93.62±1.22a

62

3

EG 10%

8.36±1.91d

91.64±1.91a

93.79±1.91a

65

5

EG 10%

16.67±4.17bc

83.33±4.17ab

92.91±0.61a

56

10

EG 10%

11.63±1.96B

88.32±1.95A

93.44±0.63A

 

Overall

7.99±2.84d

91.78±2.75a

93.33±2.22a

63

3

EG 20%

6.11±0.94d

93.73±0.88a

93.79±1.71a

66

5

EG 20%

29.17±4.17abc

70.83±4.17bcd

94.19±3.34a

59

10

EG 20%

14.42±3.98B

85.47±1.62A

93.77±1.26A

 

Overall

26.28±9.34bc

73.72±9.34bc

90.87±2.46a

58

3

EG 40%

36.01±3.26ab

63.99±3.26bcd

91.94±1.25a

61

5

EG 40%

40.54±2.46 a

59.46±2.46d

92.21±1.98a

67

10

EG 40%

34.28±3.61A

65.73±3.61B

91.67±1.73A

 

Overall

20.11±2.69

79.84±0.52

92.96±0.58

 

Overall all

Values with different superscrit in the same column are significantly different at least (P<0.5)

ES: Equilibration solution     ET: Equilibration time VS: Vitrification solution         EG: Ethylen glycol

Table 2: Effect of equilibration solution and equilibration time on the morphology of buffalo oocytes that vitrified with solution containing 0.3 M trehalose.

 

Morphological

abnormal oocytes

Morphological

normal oocytes

Recovery rate

No. Of vitrified oocytes

Treatments

ET

ES

17.60±1.31c

82.40±1.31a

90.07±2.97a

61

3

EG 10%

19.53±2.95c

80.47±2.95a

93.92±3.08a

67

5

EG 10%

23.38±2.19bc

76.62±2.19ab

92.79±1.37a

69

10

EG 10%

20.17±1.41B

79.83±1.41A

93.59±1.31A

 

Overall

17.00±3.84c

82.99±3.84a

92.87±1.10a

69

3

EG 20%

16.32±0.95c

83.68±0.95a

92.35±1.66a

66

5

EG 20%

26.18±2.25bc

74.21±2.59ab

92.13±1.44a

63

10

EG 20%

19.84±2.06B

80.29±2.05A

92.45±0.72A

 

Overall

33.17±6.27ab

66.83±6.27bc

91.45±2.28a

71

3

EG 40%

33.29±5.79ab

66.71±5.79bc

91.10±0.58a

68

5

EG 40%

41.57±2.15a

58.43±2.16c

92.65±1.12a

67

10

EG 40%

36.01±2.89A

63.71±2.93B

91.74±0.79A

 

Overall

25.34±1.92

75.89±2.08

92.59±0.56

 

Overall all

 

Values with different superscrit in the same column are significantly different at least (P<0.5)

ES: Equilibration solution     ET: Equilibration time  VS: Vitrification solution         EG: Ethylen glycol

 

Table 3:  Effect of equilibration solution and equilibration time on the morphology of buffalo oocytes that vitrified with solution containing 20% DMSO.

 

Morphological

abnormal oocytes

Morphological

normal oocytes

Recovery rate

No. Of vitrified oocytes

Treatments

ET

ES

12.24±1.05bc

87.76±0.69ab

94.93±1.05a

78

3

EG 10%

14.68±0.87bc

85.32±0.87ab

93.16±5.04a

73

5

EG 10%

15.96±1.17b

84.04±1.53b

93.32±1.17a

74

10

EG 10%

14.29±0.77B

85.71±0.77B

93.80±1.55A

 

Overall

8.54±0.61c

91.46±0.61a

94.96±3.41a

75

3

EG 20%

10.23±2.39bc

89.77±2.39ab

91.95±2.71a

77

5

EG 20%

12.71±2.10bc

87.29±2.10ab

92.89±1.06a

69

10

EG 20%

10.49±1.11C

89.51±1.11A

93.27±1.37A

 

Overall

25.24±1.99a

74.76±1.99c

90.62±0.87a

73

3

EG 40%

29.96±2.49a

70.04±2.49c

92.39±0.25a

79

5

EG 40%

39.34±1.13a

60.66±1.13c

92.67±2.23a

82

10

EG 40%

31.51±2.29A

68.49±2.29C

91.89±0.76A

 

Overall

17.77±1.98

81.23±1.98

92.98±0.72

 

Overall all

 

Values with different superscrit in the same column are significantly different at least (P<0.5)

ES: Equilibration solution     ET: Equilibration time  VS: Vitrification solution         EG: Ethylen glycol

Effect of oocytes vitrification on the in vitro maturation rate:

The results presented in table 4, showed that, vitrification of buffalo oocytes with different vitrification solutions, sucrose, trehalose or DMSO,  significantly (P < 0.5) decreased the in vitro maturation rate (47.27, 26.92 and 42.03%, respectively) compared to the control treatnent (78.67%).  Data presented in Table 4, also revealed that among  the different vitrification solutions, using sucrose or DMSO in the vitrification solution significantly increased (P < 0.5) the in vitro oocyte maturation rate (47.27 and 42.03%, respectively) compared  to trehalose (26.92%).

 

Table 4: Effect of equilibration solution, equilibration time and vitrification solutions on the in vitro oocytes maturation rate.

 

Maturation rate

No.                     (%)

No. of oocytes

Treatments

VS

ET

ES

26                 (47.27) b

55

Sucrose

5

EG 20%

14                  (26.92) c

52

Trehalose

5

EG 20%

29                  (42.03) b

69

DMSO

3

EG 20%

59                  (78.67) a

75

Control

 

Values with different superscrit in the same column are significantly different at least (P<0.5)

ES: Equilibration solution     ET: Equilibration time  VS: Vitrification solution         EG: Ethylen glycol

 

Effect of oocytes vitrification on the in vitro fertilization rate:

The results presented in table 5, revealed that, vitrification of buffalo oocytes with different vitrification solutions, sucrose, trehalose or DMSO, significantly (P < 0.5) decreased the in vitro fertilization rate (30.36, 13.21 and 23.08%, respectively) compared to the control treatnent (58.73%). Using sucrose in the vitrification solution significantly increased (P < 0.5) the in vitro fertilization rate (30.36%) compared to trehalose (13.21%).

 

Table 5: Effect of equilibration solution, equilibration time and vitrification solutions on the in vitro oocytes fertilization rate.

Fertilization rate  

No.        (%)

Penetration rate   

No.       (%)

No. of oocytes

Treatments

VS

ET

ES

17     (30.36) b

24     (42.86)b

56

Sucrose

5

   EG 20%

7       (13.21) c

13     (24.53)c

53

Trehalose

5

EG 20%

12     (23.08) bc

21    (40.38)bc

        52

DMSO

3

EG 20%

37      (58.73) a

43    (68.25) a

63

Control

 

Values with different superscrit in the same column are significantly different at least (P<0.5)

ES: Equilibration solution     ET: Equilibration time  VS: Vitrification solution         EG: Ethylen glycol

Effect of oocytes vitrification on the in vitro embryo development:

The results presented in Table 6, showed that, vitrification of buffalo oocytes with different vitrification solutions, sucrose, trehalose or DMSO, significantly (P < 0.5) decreased the cleavage rate (23.91, 6.67 and 21.43%, respectively) and the morula development (4.35, 0.00 and 2.38%, respectively) compared to the control treatment (44.64 and 19.64%, respectively). The current results also showed that, all the oocytes that vitrified in differant vitrification solutions failed to develop to the blastocyst stage compared to the control treatment (10.71%).  Among the different vitrification solutions, using sucrose in the vitrification solution yielded the highest cleavage rate and the morula stage development (23.91 and 4.35%, respectively). Meanwhile, using trehalose in the vitrification solution yielded the lowest percentage of cleavage rate (6.67%) and all the vitrified oocytes in this solution failed to develop to the morula or the blastocyst stages.

 

Table 6: Effect of equilibration solution, equilibration time and vitrification solutions on the in vitro buffalo embryo development.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

 

Blastocyst

No.   (%)

Morula

No.  (%)

Cleavage rate

No.                (%)

No. of oocytes

Treatments

VS

ET

ES

0   (0.00)b

2   (4.35)b

11               (23.91)b

46

Sucrose

5

EG20%

0   (0.00)b

0    (0.00)c

3                  (6.67)c

45

Trehalose

5

EG20%

0   (0.00)b

1   2.38)bc

9                 (21.43)b

42

DMSO

3

EG20%   

6   (10.71)a                                                                                                                                                                                                                                                  

11 (19.64)a

25                (44.64)a

56

Control

 

Values with different superscrit in the same column are significantly different at least (P<0.5)

ES: Equilibration solution     ET: Equilibration time  VS: Vitrification solution         EG: Ethylen glycol

 

Discussion

               

The cryopreservation of immature oocytes would facilitate the application of assisted reproductive procedures, such as in vitro fertilization, cloning, and stem cell biology. Improvement of the vitrification method, optimization of vitrification solution contents, exposure time to vitrification solution and/or warming method may facilitate development to the blastocyst stage after vitrification of buffalo oocytes. The exposure period of the immature buffalo oocytes to cryoprotectants is of critical importance. Oocytes are generally equilibrated in a solution containing low concentration of cryoprotectants before very short exposure to vitrification solution (Wood et al., 1993). The present results revealed that, the recovery rate of morphologically normal oocytes differed significantly according to the ethylene glycol concentrations in the equilibration solutions and the equilibration times.  The present results also demonstrated that, high concentration of ethylene glycol (40%) combined to equilibration time (10 min) with the vitrification solutions were detrimental to the morphological characteristics of oocytes. This effect is in consistent with Stachecki et al. (1998), Wani et al. (2004) and Martins et al. (2005) who found that, the toxicity of cryoprotectants varies with concentration and exposure time; the lower the concentration and the shorter the exposure time, the less toxic they are to embryo development. This may be due to biochemical (inactivation of enzymes needed for meiotic progression) and/or biophysical events (lipid elution from membranes) instead of osmotic stress (Im et al., 1997).  Moreover, the ethylene glycol and DMSO, commonly used cryoprotectants in vitrification protocols, cause transient increases in intracellular calcium in the matured mouse oocytes (Larman et al. 2006). Elevated and sustained increases in intracellular calcium can lead to inappropriate activation of proteases and phospholipases, degeneration and apoptosis (Orrenius et al., 2003; Takahashi et al., 2004)and consequantly a decrease in oocyte viability. The oocyte is a large single cell, with a small surface/volume ratio, and surrounded by several cumulus cell layers, that reduces the cryoprotectants entrance into the cell (Massip, 2003). Factors that influence the passage velocity of cryoprotectants through the cell membrane and entrance into the ooplasm are important in oocyte vitrification. The molecular weight (MW) of ethylene glycol, sucrose, trehalose and DMSO and their concentrations in the vitrification solutions are likely to have influenced the differences in the recovery rate of mophologically normal oocytes. 

The present results revealed that, in spite of high recovery rate of morphologically normal oocytes, the rates of in vitro maturation, fertilization and embryo development were significantly lower in vitrified-warmed oocytes compared to that of control. These results are in consistent with Lim et al. (1999), Saxena and Maurya, (1999), Dhali et al. (2000), Succu et al. (2005) and Kelly et al. (2005). One of the factors that limit the maturation rate of the vitrified oocytes is the occurrence of cold injury during the process. Cold injury results in irreversible damage of the plasma membrane during short exposures to low temperatures prior to freezing (Arav et al., 1993). Moreover, vitrification would lead to expansion of cumulus cells and irregular distribution of cortical granules probably due to damage of the gap junctions between cumulus and oocytes (Arav et al., 1993 and Hurt et al. 2000). Furthermore, the greater lipid content present in the buffalo oocytes may also be one of the factors responsible for low maturation rates, as it has been reported that the more lipid content present in the oocytes makes them more sensitive to chilling injury (Ledda et al., 2001). In addition, there are also other multifactorial causes for the reduced maturation rates of the GV stage oocytes, including toxic effects of cryoprotectants, ultrastructure damage to the oocytes and deleterius effects on chromosomes and other cytoplasmic structures (Martino et al., 1996 and Park et al., 1997).

       Moreover, the decreased in vitro fertilization and embryo development of the vitrified immature oocytes observed in the present study may be attributed to the vitrification critically damaged plasma membranes, or induced zona hardening of the vitrified oocytes and decrease the ability of fertilization (Larman et al., 2006).  It is possible that the poor embryo development of buffalo oocytes following vitrification is due to their higher lipid content (Boni et al., 1992) that has been linked to an increased sensitivity to chilling injuries.

Therefore, from the current results we can conclude that immature buffalo oocytes could be frozen by vitrification technique as demonstrated by their ability to cleave and to develop in vitro.  Acceptable vitrification protochol of buffalo oocytes was observed when immature buffalo oocytes were vitrified using 20% EG in the ES, an equilibration time of 5 min, and a VS containing 20% EG and 0.5 M sucrose. However, extensive studies are needed to improve the efficiency of oocyte vitrification in buffalo species with the prospect to utilize vitrified oocytes as a source of gametes for the in vitro embryo production and other reproductive technologies.

 

References

 

Arav, A.; Shehu, D. and Mattioli, M. (1993): Osmotic and cytotoxic study of vitrification of immature bovine oocytes. J. Reprod. Fertil.; 99: 353–358.

Bankowski, B.J.; Lyerly, A.D.; Faden,R.R. and Wallach, E.E. (2005): The social implications of embryo cryopreservation. Fertil. Steril.; 84: 823-832.

Boni, R.; Sangella, L.; Dale, B.; Rovello, S.; Di Palo, R. and Barbieri, V. (1992): Maturazione in vitro di oociti bufalini: indagine ultrastrutturale. Acta Med. Vet.;38:153–161.

Cha, K. Y.; Chung, H. M.; Lim, J. M.; Ko, J. J.; Han, S. Y.; Choi, D. H.; Yoon, T. K. (2000): Freezing immature oocytes.  Mol. Cell. Endocrinol. ; 169: 43–47.

Coticchio, G.; Bonu, M.A.; Borini, A. and Flamigni, C. (2004): Oocyte cryopreservation: a biological perspective. Eur. J. Obstet. Gynecol. Reprod. Biol.; 115: 2–7.

Costa, E.P.; Vale Filho, V.R.; Nogueira, J.C.; Sá, W.F. and Costa, A.H. (1997): Technique for evaluating nuclear maturation of bovine oocytes cultured in vitro. Braz Arch. Vet. Med. Anim. Sci.; 49: 433-440.

Costat Computer Program Copyright (1986): Version 3.03 copyright Cottort Software.

Dhali, A.; Manik, R.S.; Das, S.K.; Singla, S.K. and Palta, P. (2000): Post-vitrification survival and in vitro maturation rate of buffalo (Bubalus bubalis) oocytes: effect of ethylene glycol concentration and exposure time. Anim. Reprod. Sci.; 63:159–165.

Dinnyes, A.; Day, Y.; Jiang, S. and Yang, X. (2000):High developmental rates of vitrified bovine oocytes following parthenogenetic activation, in vitro fertilization, and somatic nuclear transfer. Biol. Reprod. ; 63: 513–518.

Gasparrini, B. (2002): In vitro embryo production in buffalo species: state of the art. Theriogenology; 57: 237–256.

Gasparrini, B.; Boccia, L.; Marchandise, J.; Di Palo, R.; George, F.; Donnay, I. and Zicarelli, L. (2006):Enrichment of in vitromaturation medium for buffalo (Bubalus bubalis) oocytes with thiol compounds: Effects of cystine on glutathione synthesis and embryo development. Theriogenology; 65: 275–287.

Holt, W.V. (2000): Fundamental aspects of sperm cryobiology: the importance of species and individual differences. Theriogenology; 53: 47-58. 

Hurt, A.E.; Landim, F.; Seidel, G.E. and Squires, E.L. (2000): Vitrification of immature and mature equine and bovine oocytes in an ethylene glycol, ficoll and sucrose solution using open-pulled straws. Theriogenology; 54: 119–128.

Im, K.S.; Kang, J.K. and Kim, H.S. (1997): Effects of cumuluscells, different cryoprotectants, various maturation stages and preincubation before insemination on developmental capacity of frozen-thawed bovine oocytes. Theriogenology; 47:881-891.

Kelly, J.; Kleemann, D.; Kuwayama, M. and Walker, S. (2005): Effect of                                                                                                  cysteamine on survival of bovine and ovine oocytes vitrified using the minimum volume cooling (MVC) cryotop method (abstract). Reprod. Fertil. Dev.; 18: 158–1158.

Kuleshova, L.L.; MacFarlane, D.R.; Trounson, A.O. and Shaw, J.M. (1999): Sugars exert a major influence on the vitrification properties of ethylene glycol-based solutions and have a low toxicity to embryos and oocytes. Cryobiology; 38:119-130.

Larman, M.G.; Sheehan, C.B. and Gardner, D.K. (2006): Calcium-free vitrification reduces cryoprotectant-induced zona pellucida hardening and increases fertilization rates in mouse oocytes. Reproduction; 131: 53–61.

Ledda, S.; Leoni, G.L.; Bogliolo, L. and Naitana, S. (2001): Oocyte cryopreservation and ovarian tissue banking. Theriogenology; 55:1359-1371.

Lim, J.M.; Ko, J.J.; Hwang, W.S.; Chung, H.M. and Niwa, K. (1999): Development of in vitro matured bovine oocytes after cryopreservation with different cryoprotectants. Theriogenology; 51:1303-1310.

Maclellan, L.J.; Carnevale, E.M.; Coutinho da Silva, M.A.; Scoggin, C.F.; Bruemmer, J.E. and Squires, E.L. (2002):Pregnancies from vitrified equine oocytes collected from super-stimulated and non-stimulatedmares. Theriogenology; 58:911-919.

Martino, A.; Songsasen, N. and Leibo, S.P. (1996): Development into blastocysts of bovine oocytes cryopreserved by ultra-rapid cooling. Biol. Reprod. ; 54: 1059–1069.

Martins, R.D.; Costa, E.P.; Chagas, S.C.; Ignàcio, F. S.; Torres, C.A. A. and McManus, C. (2005):Effects of vitrification of immature bovine oocytes on in vitro maturation.  Anim. Reprod.; 2: 128-134.

Massip, A. (2003): Cryopreservation of bovine oocytes: current status and recent developments. Reprod. Nutr. Dev.; 43: 325-330.

Orrenius, S.; Zhivotovsky, B. and Nicotera, P. (2003):Regulation of cell death: the calcium-apoptosis link. Nat. Rev. Mol. Cell Biol.; 4:552-565.

Otoi, T.; Yamamoto, K.; Koyama, N.; Tachikawa, S. and Suzuki, T. (1998): Cryopreservation of mature bovine oocytes by vitrification in straws. Cryobiology; 37:77-85.

Papis, K.; Shimizu, M. and Izaike, Y.  (2000):Factors affecting the survivability of

bovine oocytes vitrified in droplets. Theriogenology; 15:651–658.

Park, S.; Son, W.; Lee, S.; Lee, K.; Ko, J. and Cha, K. (1997): Chromosome and spindle configuration of human oocytes matured in vitro after cryopreservation at germinal vesicle stage. Fertil. Steril.; 68: 920–926.

Puhlev, I.; Guo, N.; Brown, D. R. and Levine, F. (2001):Dessication tolerance in human cells. Cryobiology; 42:207-217.

Rayos, A.A.; Takahashi, Y.; Hishinuma, M. and Kanagawa, H. (1994): Quick freezing of unfertilized mouse oocytes using ethylene glycol with sucrose or trehalose. J. Reprod. Fertil.; 100:123-129.

Saxena, M.K. and Maurya, S.N. (1999): One step freezing of immature buffalo oocytes. Indian J. Anim. Reprod.; 20: 3.

Shaw, J.M.; Kuleshova, L.L.; MacFarlane, D.R. and Trounson, A.O. (1997): Vitrification properties of solutions of ethylene glycol in saline containing PVP, Ficoll, or dextran. Cryobiology; 35: 219–229.

Shaw, J.; Oranratnachai, A. and Trounson, A. (2000): Fundamental cryobiology of mammalian oocytes and ovarian tissue. Theriogenology; 53: 59–72.

Stachecki, J.J.; Cohen, J. and Willadsen, S. (1998):Detrimental effects of sodium during mouse oocyte cryopreservation. Biol. Reprod.; 59: 359-400.

Takahashi, T.; Igarashi, H.; Doshida, M.; Takahashi, K.; Nakahara, K.; Tezuka N. and Kurachi, H. (2004):Lowering intracellular and extracellular calcium contents prevents cytotoxic effects of ethylene glycol-based vitrification solution in unfertilized mouse oocytes. Mol. Reprod. Dev.; 68:250–258.

Vajta, G. (2000): Vitrification of the oocytes and embryos of domestic animals. Anim. Reprod. Sci.; 61: 357–364.

Vieira, A.D.; Mezzalira, A.; Barbieri, D.P.; Lehmkuhl, R.C.; Rubin, M.I. B. and Vajta, G. (2002): Calves born after open pulled straw vitrification of immature bovine oocytes. Cryobiology; 45: 91–94.

Vieira, A.D.; Mezzalira, A.; Barbieri, D.P.; Lehmkuhl, R.C.; Rubin, M.I. B.; Wani, N.A.; Misra, A.K. and Maurya, S.N. (2004): Maturation rates of vitrified-thawed immature buffalo (Bubalus bubalis) oocytes: effect of different types of cryoprotectants. Anim. Reprod. Sci.; 84: 327–335.

Wani, N.A.; Maurya, S.N.; Misra, A.K.; Saxena, V.B. and Lakhchaura, B.D. (2004):Effect of cryoprotectants and their concentration on in vitro development of vitrified–warmed immature oocytes in buffalo (Bubalus bubalis). Theriogenology; 61: 831–842.

Wood, M.J.; Barros, C.; Candy, C.J.; Carroll, J.; Melendez, J. and Whittingham, D.J. (1993):High rates of survival and fertilization of mouse and hamster oocytes after vitrification in dimethyl sulfoxide. Biol. Reprod.; 49: 489–495.

Zicarelli, L. (1997):Superovulatory response in buffaloes bred in Italy. In: Third Course on Biotechnology of Reproduction in Buffaloes, Caserta, Italy, pp. 167–188.

 

 

 

 

References
 
Arav, A.; Shehu, D. and Mattioli, M. (1993): Osmotic and cytotoxic study of vitrification of immature bovine oocytes. J. Reprod. Fertil.; 99: 353–358.
Bankowski, B.J.; Lyerly, A.D.; Faden,R.R. and Wallach, E.E. (2005): The social implications of embryo cryopreservation. Fertil. Steril.; 84: 823-832.
Boni, R.; Sangella, L.; Dale, B.; Rovello, S.; Di Palo, R. and Barbieri, V. (1992): Maturazione in vitro di oociti bufalini: indagine ultrastrutturale. Acta Med. Vet.;38:153–161.
Cha, K. Y.; Chung, H. M.; Lim, J. M.; Ko, J. J.; Han, S. Y.; Choi, D. H.; Yoon, T. K. (2000): Freezing immature oocytes.  Mol. Cell. Endocrinol. ; 169: 43–47.
Coticchio, G.; Bonu, M.A.; Borini, A. and Flamigni, C. (2004): Oocyte cryopreservation: a biological perspective. Eur. J. Obstet. Gynecol. Reprod. Biol.; 115: 2–7.
Costa, E.P.; Vale Filho, V.R.; Nogueira, J.C.; Sá, W.F. and Costa, A.H. (1997): Technique for evaluating nuclear maturation of bovine oocytes cultured in vitro. Braz Arch. Vet. Med. Anim. Sci.; 49: 433-440.
Costat Computer Program Copyright (1986): Version 3.03 copyright Cottort Software.
Dhali, A.; Manik, R.S.; Das, S.K.; Singla, S.K. and Palta, P. (2000): Post-vitrification survival and in vitro maturation rate of buffalo (Bubalus bubalis) oocytes: effect of ethylene glycol concentration and exposure time. Anim. Reprod. Sci.; 63:159–165.
Dinnyes, A.; Day, Y.; Jiang, S. and Yang, X. (2000):High developmental rates of vitrified bovine oocytes following parthenogenetic activation, in vitro fertilization, and somatic nuclear transfer. Biol. Reprod. ; 63: 513–518.
Gasparrini, B. (2002): In vitro embryo production in buffalo species: state of the art. Theriogenology; 57: 237–256.
Gasparrini, B.; Boccia, L.; Marchandise, J.; Di Palo, R.; George, F.; Donnay, I. and Zicarelli, L. (2006):Enrichment of in vitromaturation medium for buffalo (Bubalus bubalis) oocytes with thiol compounds: Effects of cystine on glutathione synthesis and embryo development. Theriogenology; 65: 275–287.
Holt, W.V. (2000): Fundamental aspects of sperm cryobiology: the importance of species and individual differences. Theriogenology; 53: 47-58. 
Hurt, A.E.; Landim, F.; Seidel, G.E. and Squires, E.L. (2000): Vitrification of immature and mature equine and bovine oocytes in an ethylene glycol, ficoll and sucrose solution using open-pulled straws. Theriogenology; 54: 119–128.
Im, K.S.; Kang, J.K. and Kim, H.S. (1997): Effects of cumuluscells, different cryoprotectants, various maturation stages and preincubation before insemination on developmental capacity of frozen-thawed bovine oocytes. Theriogenology; 47:881-891.
Kelly, J.; Kleemann, D.; Kuwayama, M. and Walker, S. (2005): Effect of                                                                                                  cysteamine on survival of bovine and ovine oocytes vitrified using the minimum volume cooling (MVC) cryotop method (abstract). Reprod. Fertil. Dev.; 18: 158–1158.
Kuleshova, L.L.; MacFarlane, D.R.; Trounson, A.O. and Shaw, J.M. (1999): Sugars exert a major influence on the vitrification properties of ethylene glycol-based solutions and have a low toxicity to embryos and oocytes. Cryobiology; 38:119-130.
Larman, M.G.; Sheehan, C.B. and Gardner, D.K. (2006): Calcium-free vitrification reduces cryoprotectant-induced zona pellucida hardening and increases fertilization rates in mouse oocytes. Reproduction; 131: 53–61.
Ledda, S.; Leoni, G.L.; Bogliolo, L. and Naitana, S. (2001): Oocyte cryopreservation and ovarian tissue banking. Theriogenology; 55:1359-1371.
Lim, J.M.; Ko, J.J.; Hwang, W.S.; Chung, H.M. and Niwa, K. (1999): Development of in vitro matured bovine oocytes after cryopreservation with different cryoprotectants. Theriogenology; 51:1303-1310.
Maclellan, L.J.; Carnevale, E.M.; Coutinho da Silva, M.A.; Scoggin, C.F.; Bruemmer, J.E. and Squires, E.L. (2002):Pregnancies from vitrified equine oocytes collected from super-stimulated and non-stimulatedmares. Theriogenology; 58:911-919.
Martino, A.; Songsasen, N. and Leibo, S.P. (1996): Development into blastocysts of bovine oocytes cryopreserved by ultra-rapid cooling. Biol. Reprod. ; 54: 1059–1069.
Martins, R.D.; Costa, E.P.; Chagas, S.C.; Ignàcio, F. S.; Torres, C.A. A. and McManus, C. (2005):Effects of vitrification of immature bovine oocytes on in vitro maturation.  Anim. Reprod.; 2: 128-134.
Massip, A. (2003): Cryopreservation of bovine oocytes: current status and recent developments. Reprod. Nutr. Dev.; 43: 325-330.
Orrenius, S.; Zhivotovsky, B. and Nicotera, P. (2003):Regulation of cell death: the calcium-apoptosis link. Nat. Rev. Mol. Cell Biol.; 4:552-565.
Otoi, T.; Yamamoto, K.; Koyama, N.; Tachikawa, S. and Suzuki, T. (1998): Cryopreservation of mature bovine oocytes by vitrification in straws. Cryobiology; 37:77-85.
Papis, K.; Shimizu, M. and Izaike, Y.  (2000):Factors affecting the survivability of
bovine oocytes vitrified in droplets. Theriogenology; 15:651–658.
Park, S.; Son, W.; Lee, S.; Lee, K.; Ko, J. and Cha, K. (1997): Chromosome and spindle configuration of human oocytes matured in vitro after cryopreservation at germinal vesicle stage. Fertil. Steril.; 68: 920–926.
Puhlev, I.; Guo, N.; Brown, D. R. and Levine, F. (2001):Dessication tolerance in human cells. Cryobiology; 42:207-217.
Rayos, A.A.; Takahashi, Y.; Hishinuma, M. and Kanagawa, H. (1994): Quick freezing of unfertilized mouse oocytes using ethylene glycol with sucrose or trehalose. J. Reprod. Fertil.; 100:123-129.
Saxena, M.K. and Maurya, S.N. (1999): One step freezing of immature buffalo oocytes. Indian J. Anim. Reprod.; 20: 3.
Shaw, J.M.; Kuleshova, L.L.; MacFarlane, D.R. and Trounson, A.O. (1997): Vitrification properties of solutions of ethylene glycol in saline containing PVP, Ficoll, or dextran. Cryobiology; 35: 219–229.
Shaw, J.; Oranratnachai, A. and Trounson, A. (2000): Fundamental cryobiology of mammalian oocytes and ovarian tissue. Theriogenology; 53: 59–72.
Stachecki, J.J.; Cohen, J. and Willadsen, S. (1998):Detrimental effects of sodium during mouse oocyte cryopreservation. Biol. Reprod.; 59: 359-400.
Takahashi, T.; Igarashi, H.; Doshida, M.; Takahashi, K.; Nakahara, K.; Tezuka N. and Kurachi, H. (2004):Lowering intracellular and extracellular calcium contents prevents cytotoxic effects of ethylene glycol-based vitrification solution in unfertilized mouse oocytes. Mol. Reprod. Dev.; 68:250–258.
Vajta, G. (2000): Vitrification of the oocytes and embryos of domestic animals. Anim. Reprod. Sci.; 61: 357–364.
Vieira, A.D.; Mezzalira, A.; Barbieri, D.P.; Lehmkuhl, R.C.; Rubin, M.I. B. and Vajta, G. (2002): Calves born after open pulled straw vitrification of immature bovine oocytes. Cryobiology; 45: 91–94.
Vieira, A.D.; Mezzalira, A.; Barbieri, D.P.; Lehmkuhl, R.C.; Rubin, M.I. B.; Wani, N.A.; Misra, A.K. and Maurya, S.N. (2004): Maturation rates of vitrified-thawed immature buffalo (Bubalus bubalis) oocytes: effect of different types of cryoprotectants. Anim. Reprod. Sci.; 84: 327–335.
Wani, N.A.; Maurya, S.N.; Misra, A.K.; Saxena, V.B. and Lakhchaura, B.D. (2004):Effect of cryoprotectants and their concentration on in vitro development of vitrified–warmed immature oocytes in buffalo (Bubalus bubalis). Theriogenology; 61: 831–842.
Wood, M.J.; Barros, C.; Candy, C.J.; Carroll, J.; Melendez, J. and Whittingham, D.J. (1993):High rates of survival and fertilization of mouse and hamster oocytes after vitrification in dimethyl sulfoxide. Biol. Reprod.; 49: 489–495.
Zicarelli, L. (1997):Superovulatory response in buffaloes bred in Italy. In: Third Course on Biotechnology of Reproduction in Buffaloes, Caserta, Italy, pp. 167–188.